{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:33:51Z","timestamp":1782311631489,"version":"3.54.5"},"update-to":[{"DOI":"10.1002\/14651858.cd001146.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T00:00:00Z","timestamp":1508803200000}}],"reference-count":157,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001146.pub5","type":"journal-article","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T04:24:19Z","timestamp":1508819059000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Early (&lt; 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants"],"prefix":"10.1002","volume":"2018","author":[{"given":"Lex W","family":"Doyle","sequence":"first","affiliation":[{"name":"The University of Melbourne; Department of Obstetrics and Gynaecology; Parkville Victoria Australia 3052"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanie L","family":"Cheong","sequence":"additional","affiliation":[{"name":"The Royal Women\u2019s Hospital; Newborn Research Centre and Neonatal Services; Locked Bag 300 20 Flemington Rd Melbourne Victoria Australia 3052"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Ehrenkranz","sequence":"additional","affiliation":[{"name":"Yale University; Department of Pediatrics; PO Box 208064 333 Cedar Street New Haven Connecticut USA 06520-8064"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry L","family":"Halliday","sequence":"additional","affiliation":[{"name":"Retired Honorary Professor of Child Health, Queen's University; 74 Deramore Park South Belfast Northern Ireland UK BT9 5JY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,10,24]]},"reference":[{"issue":"8","key":"10.1002\/14651858.CD001146.pub5-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s00431-005-1645-8","article-title":"Early neonatal dexamethasone treatment for prevention of bronchopulmonary dysplasia. Randomised trial and meta-analysis evaluating the duration of dexamethasone therapy","volume":"164","author":"Anttila","year":"2005","journal-title":"European Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD001146.pub5-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1542\/peds.50.4.526","article-title":"A controlled trial of hydrocortisone therapy in infants with respiratory distress syndrome","volume":"50","author":"Baden","year":"1972","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD001146.pub5-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1542\/peds.53.6.877","article-title":"Sequelae of early steroid administration to the newborn infant","volume":"53","author":"Fitzhardinge","year":"1974","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD001146.pub5-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jpeds.2012.01.014","article-title":"Feasibility study of early blood pressure management in extremely preterm infants","volume":"161","author":"Batton","year":"2012","journal-title":"Journal of Pediatrics"},{"issue":"10030","key":"10.1002\/14651858.CD001146.pub5-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/S0140-6736(16)00202-6","article-title":"Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial","volume":"387","author":"Baud","year":"2016","journal-title":"Lancet"},{"issue":"13","key":"10.1002\/14651858.CD001146.pub5-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1001\/jama.2017.2692","article-title":"Association between early low-dose hydrocortisone therapy in extremely preterm neonates and neurodevelopmental outcomes at 2 years of age","volume":"317","author":"Baud","year":"2017","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001146.pub5-BIB0008|cit7","unstructured":"Biswas S Personal communication email 2002"},{"issue":"1","key":"10.1002\/14651858.CD001146.pub5-BIB0007|cit8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1203\/00006450-200301000-00011","article-title":"Pulmonary effects of triiodothyronine (T3) and hydrocortisone (HC) supplementation in preterm infants less than 30 weeks gestation: results of the THORN trial - thyroid hormone replacement in neonates","volume":"53","author":"Biswas","year":"2003","journal-title":"Pediatric Research"},{"issue":"4","key":"10.1002\/14651858.CD001146.pub5-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000098168","article-title":"Early low-dose hydrocortisone in very preterm infants: a randomized placebo-controlled trial","volume":"91","author":"Bonsante","year":"2007","journal-title":"Neonatology"},{"issue":"2","key":"10.1002\/14651858.CD001146.pub5-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/sj.jp.7211193","article-title":"A randomized-controlled trial of prophylactic hydrocortisone supplementation for the prevention of hypotension in extremely low birth weight infants","volume":"25","author":"Efird","year":"2005","journal-title":"Journal of Perinatology"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD001146.pub5-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1542\/peds.104.1.91","article-title":"A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: a randomized trial","volume":"104","author":"Garland","year":"1999","journal-title":"Pediatrics"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD001146.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0022-3476(05)72461-6","article-title":"Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: a controlled trial","volume":"117","author":"Halac","year":"1990","journal-title":"Journal of Pediatrics"},{"issue":"8","key":"10.1002\/14651858.CD001146.pub5-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s12098-013-1151-3","article-title":"Adding hydrocortisone as 1st line of inotropic treatment for hypotension in very low birth weight infants","volume":"81","author":"Hochwald","year":"2014","journal-title":"Indian Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD001146.pub5-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0022-3476(99)70132-0","article-title":"A single very early dexamethasone dose improves respiratory and cardiovascular adaptation in preterm infants","volume":"135","author":"Kopelman","year":"1999","journal-title":"Journal of Pediatrics"},{"issue":"7","key":"10.1002\/14651858.CD001146.pub5-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1080\/14767050600736754","article-title":"Nebulized pentoxifylline for prevention of bronchopulmonary dysplasia in very low birth weight infants: a pilot clinical study","volume":"19","author":"Lauterbach","year":"2006","journal-title":"Journal of Maternal-Fetal & Neonatal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD001146.pub5-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/(SICI)1099-0496(199901)27:1<21::AID-PPUL5>3.0.CO;2-Y","article-title":"Prevention of chronic lung disease in preterm infants by early postnatal dexamethasone therapy","volume":"27","author":"Lin","year":"1999","journal-title":"Pediatric Pulmonology"},{"issue":"2","key":"10.1002\/14651858.CD001146.pub5-BIB0017|cit17","first-page":"117","article-title":"Role of early postnatal dexamethasone in respiratory distress syndrome","volume":"35","author":"Mukhopadhyay","year":"1998","journal-title":"Indian Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD001146.pub5-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1542\/peds.2005-0869","article-title":"A double-blind randomized controlled study of a stress dose of hydrocortisone for rescue treatment of refractory hypotension in preterm infants","volume":"117","author":"Ng","year":"2006","journal-title":"Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD001146.pub5-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jpeds.2004.12.040","article-title":"Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infants","volume":"146","author":"Peltoniemi","year":"2005","journal-title":"Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD001146.pub5-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000164150","article-title":"Trial of early neonatal hydrocortisone: two-year follow-up","volume":"95","author":"Peltoniemi","year":"2009","journal-title":"Neonatology"},{"issue":"2","key":"10.1002\/14651858.CD001146.pub5-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/apa.13074","article-title":"Randomised trial of early neonatal hydrocortisone demonstrates potential undesired effects on neurodevelopment at preschool age","volume":"105","author":"Peltoniemi","year":"2016","journal-title":"Acta Paediatrica"},{"issue":"3","key":"10.1002\/14651858.CD001146.pub5-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s002469900290","article-title":"Effect of dexamethasone therapy on the neonatal ductus arteriosus","volume":"19","author":"Morales","year":"1998","journal-title":"Pediatric Cardiology"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD001146.pub5-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1542\/peds.98.2.204","article-title":"A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants","volume":"98","author":"Rastogi","year":"1996","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD001146.pub5-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1542\/peds.109.6.e85","article-title":"Controlled trial of early dexamethasone treatment for the prevention of chronic lung disease in preterm infants: a 3-year follow-up","volume":"109","author":"Romagnoli","year":"2002","journal-title":"Pediatrics"},{"issue":"7","key":"10.1002\/14651858.CD001146.pub5-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s001340050935","article-title":"Early postnatal dexamethasone for the prevention of chronic lung disease in high-risk preterm infants","volume":"25","author":"Romagnoli","year":"1999","journal-title":"Intensive Care Medicine"},{"issue":"5","key":"10.1002\/14651858.CD001146.pub5-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000028329","article-title":"Effect on growth of two different dexamethasone courses for preterm infants at risk of chronic lung disease. A randomized controlled trial","volume":"59","author":"Romagnoli","year":"1999","journal-title":"Pharmacology"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD001146.pub5-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1203\/00006450-199407001-00022","article-title":"Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome","volume":"36","author":"Sanders","year":"1994","journal-title":"Pediatric Research"},{"key":"10.1002\/14651858.CD001146.pub5-BIB0028|cit28","unstructured":"Sinkin RA Personal communication email 2002"},{"key":"10.1002\/14651858.CD001146.pub5-BIB0031|cit29","unstructured":"Shinwell ES Early dexamethasone therapy is associated with increased incidence of cerebral palsy Hot Topics' 99 in Neonatology 1999 240 54"},{"key":"10.1002\/14651858.CD001146.pub5-BIB0032|cit30","unstructured":"Shinwell ES Personal communication email 2002"},{"issue":"3","key":"10.1002\/14651858.CD001146.pub5-BIB0029|cit31","doi-asserted-by":"crossref","first-page":"F177","DOI":"10.1136\/fn.83.3.F177","article-title":"Early postnatal dexamethasone treatment and incidence of cerebral palsy","volume":"83","author":"Shinwell","year":"2000","journal-title":"Archives of Disease in Childhood. Fetal and Neonatal Edition"},{"issue":"1","key":"10.1002\/14651858.CD001146.pub5-BIB0030|cit32","doi-asserted-by":"crossref","first-page":"F33","DOI":"10.1136\/fn.74.1.F33","article-title":"Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome","volume":"74","author":"Shinwell","year":"1996","journal-title":"Archives of Disease in Childhood. Fetal and Neonatal Edition"},{"issue":"5","key":"10.1002\/14651858.CD001146.pub5-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000014168","article-title":"Vascular endothelial growth factor in pulmonary lavage fluid from premature infants: effects of age and postnatal dexamethasone","volume":"76","author":"D'Angio","year":"1999","journal-title":"Biology of the Neonate"},{"key":"10.1002\/14651858.CD001146.pub5-BIB0035|cit34","unstructured":"Sinkin RA Personal communication email 2002"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD001146.pub5-BIB0034|cit35","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1542\/peds.105.3.542","article-title":"Early dexamethasone - attempting to prevent chronic lung disease","volume":"105","author":"Sinkin","year":"2000","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD001146.pub5-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"226A","DOI":"10.1203\/00006450-199904020-01345","article-title":"Early postnatal dexamethasone therapy for the prevention of chronic lung disease","volume":"45","author":"Soll","year":"1999","journal-title":"Pediatric Research"},{"issue":"3","key":"10.1002\/14651858.CD001146.pub5-BIB0037|cit37","first-page":"741","article-title":"Early\u00a0postnatal\u00a0dexamethasone\u00a0therapy\u00a0for the\u00a0prevention\u00a0of\u00a0chronic\u00a0lung disease","volume":"108","author":"Vermont Oxford Network Steroid Study Group","year":"2001","journal-title":"Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD001146.pub5-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1056\/NEJM200101113440203","article-title":"Adverse effects of early dexamethasone in extremely-low-birth-weight infants","volume":"344","author":"Stark","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001146.pub5-BIB0039|cit39","doi-asserted-by":"crossref","unstructured":"Stark AR Carlo WA Vohr BR Papile L Saha S Bauer CR Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network Death or neurodevelopmental impairment at 18 to 22 months corrected age in a randomized trial of early dexamethasone to prevent death or chronic lung disease in extremely low birth weight infants Journal of Pediatrics 2014 34-9 e2 10.1016\/j.jpeds.2013.07.027","DOI":"10.1016\/j.jpeds.2013.07.027"},{"key":"10.1002\/14651858.CD001146.pub5-BIB0042|cit40","unstructured":"Subhedar NV Personal communication email 2002"},{"issue":"7239","key":"10.1002\/14651858.CD001146.pub5-BIB0040|cit41","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1136\/bmj.320.7239.941","article-title":"More trials on early treatment with corticosteroids are needed","volume":"320","author":"Subhedar","year":"2000","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD001146.pub5-BIB0041|cit42","doi-asserted-by":"crossref","first-page":"F185","DOI":"10.1136\/fn.77.3.F185","article-title":"Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants","volume":"77","author":"Subhedar","year":"1997","journal-title":"Archives of Disease in Childhood. Fetal and Neonatal Edition"},{"issue":"6","key":"10.1002\/14651858.CD001146.pub5-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1651-2227.1996.tb14132.x","article-title":"Influence of early postnatal dexamethasone therapy on ventilator dependency in surfactant-substituted preterm infants","volume":"85","author":"Suske","year":"1996","journal-title":"Acta Paediatrica"},{"issue":"1","key":"10.1002\/14651858.CD001146.pub5-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0022-3476(98)70483-4","article-title":"The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome","volume":"132","author":"Tapia","year":"1998","journal-title":"Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD001146.pub5-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000077444","article-title":"Effect of dexamethasone on tracheobronchial aspirate fluid cytology and pulmonary mechanics in preterm infants","volume":"71","author":"Vento","year":"2004","journal-title":"Pharmacology"},{"issue":"9","key":"10.1002\/14651858.CD001146.pub5-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/thx.51.9.907","article-title":"Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome","volume":"51","author":"Wang","year":"1996","journal-title":"Thorax"},{"issue":"3","key":"10.1002\/14651858.CD001146.pub5-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/(SICI)1099-0496(199703)23:3<193::AID-PPUL4>3.0.CO;2-P","article-title":"Early postnatal dexamethasone therapy may lessen lung inflammation in premature infants with respiratory distress syndrome on mechanical ventilation","volume":"23","author":"Wang","year":"1997","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD001146.pub5-BIB0049|cit48","unstructured":"Watterberg KL Personal communication email 2002"},{"issue":"6","key":"10.1002\/14651858.CD001146.pub5-BIB0048|cit49","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1542\/peds.104.6.1258","article-title":"Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants","volume":"104","author":"Watterberg","year":"1999","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD001146.pub5-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1542\/peds.2004-1159","article-title":"Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial","volume":"114","author":"Watterberg","year":"2004","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD001146.pub5-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1542\/peds.2006-3158","article-title":"Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants","volume":"120","author":"Watterberg","year":"2007","journal-title":"Pediatrics"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD001146.pub5-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0022-3476(05)80547-5","article-title":"Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study","volume":"117","author":"Yeh","year":"1990","journal-title":"Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD001146.pub5-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1651-2227.2005.tb03073.x","article-title":"The effects of early postnatal dexamethasone therapy on pulmonary outcome in premature infants with respiratory distress syndrome: a two-year follow-up study","volume":"94","author":"Lin","year":"2005","journal-title":"Acta Paediatrica"},{"issue":"10","key":"10.1002\/14651858.CD001146.pub5-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1651-2227.1998.tb01414.x","article-title":"Effects of early postnatal dexamethasone therapy on calcium homeostasis and bone growth in preterm infants with respiratory distress syndrome","volume":"87","author":"Lin","year":"1998","journal-title":"Acta Paediatrica"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD001146.pub5-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1542\/peds.104.3.476","article-title":"Early dexamethasone therapy and blood cell count in preterm infants","volume":"104","author":"Peng","year":"1999","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD001146.pub5-BIB0056|cit56","first-page":"262A","article-title":"Prevention of chronic lung disease (CLD) in premature RDS infants with early and prolonged dexamethasone (D) therapy - a multicenter double-blind controlled study","volume":"35","author":"Yeh","year":"1994","journal-title":"Pediatric Research"},{"issue":"4","key":"10.1002\/14651858.CD001146.pub5-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1542\/peds.100.4.e3","article-title":"Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial","volume":"100","author":"Yeh","year":"1997","journal-title":"Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD001146.pub5-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1542\/peds.101.5.e7","article-title":"Early dexamethasone therapy in preterm infants: a follow-up study","volume":"101","author":"Yeh","year":"1998","journal-title":"Pediatrics"},{"issue":"13","key":"10.1002\/14651858.CD001146.pub5-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1056\/NEJMoa032089","article-title":"Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity","volume":"350","author":"Yeh","year":"2004","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001146.pub5-BIB0060|cit60","unstructured":"Ariagno RL Sweeney TE Baldwin RB Inguillo D Martin D Controlled trial of dexamethasone in preterm infants at risk for bronchopulmonary dysplasia: lung function, clinical course and outcome at three years (as supplied 2000) Data on file"},{"key":"10.1002\/14651858.CD001146.pub5-BIB0061|cit61","first-page":"A125","article-title":"Dexamethasone effects on lung function and risks in 3 week old ventilatory dependent preterm infants","volume":"135","author":"Ariagno","year":"1987","journal-title":"American Reviews of Respiratory Disease"},{"issue":"1","key":"10.1002\/14651858.CD001146.pub5-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1542\/peds.75.1.106","article-title":"Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia","volume":"75","author":"Avery","year":"1985","journal-title":"Pediatrics"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD001146.pub5-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0022-3476(95)70410-8","article-title":"Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant","volume":"126","author":"Brozanski","year":"1995","journal-title":"Journal of Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD001146.pub5-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/07315724.1995.10718536","article-title":"Pulse dexamethasone does not impair growth and body composition of very low birth weight infants","volume":"14","author":"Gilmour","year":"1995","journal-title":"Journal of the American College of Nutrition"},{"issue":"4","key":"10.1002\/14651858.CD001146.pub5-BIB0065|cit65","first-page":"259A","article-title":"One year outcome of infants treated with pulse dexamethasone for prevention of BPD","volume":"37","author":"Hofkosh","year":"1995","journal-title":"Pediatric Research"},{"issue":"3","key":"10.1002\/14651858.CD001146.pub5-BIB0066|cit66","first-page":"421","article-title":"Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial","volume":"88","author":"Collaborative Dexamethasone Trial Group","year":"1991","journal-title":"Pediatrics"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD001146.pub5-BIB0067|cit67","first-page":"897","article-title":"Controlled trial of dexamethasone in neonatal chronic lung disease: a 3-year follow-up","volume":"96","author":"Jones","year":"1995","journal-title":"Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD001146.pub5-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1542\/peds.2004-1818","article-title":"Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: I. Neurologic, psychological, and educational outcomes","volume":"116","author":"Jones","year":"1995","journal-title":"Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD001146.pub5-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1542\/peds.2004-1819","article-title":"Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: II. Respiratory status, growth, and blood pressure","volume":"116","author":"Jones","year":"2005","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD001146.pub5-BIB0071|cit70","unstructured":"Cummings JJ Personal communication email 2002"},{"issue":"23","key":"10.1002\/14651858.CD001146.pub5-BIB0070|cit71","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1056\/NEJM198906083202301","article-title":"A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia","volume":"320","author":"Cummings","year":"1989","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD001146.pub5-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1542\/peds.2004-0956","article-title":"Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease","volume":"115","author":"Gross","year":"2005","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD001146.pub5-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"A119","DOI":"10.1136\/archdischild-2012-302724.0405","article-title":"Clinical effectiveness of early administration of caffeine and low-dose hydrocortisone to preterm newborns with a high risk of BPD development","volume":"97","author":"Dobryansky","year":"2012","journal-title":"Archives of Disease in Childhood"},{"issue":"1","key":"10.1002\/14651858.CD001146.pub5-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1542\/peds.2004-2843","article-title":"Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial","volume":"117","author":"Doyle","year":"2006","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD001146.pub5-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1542\/peds.2006-2806","article-title":"Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone","volume":"119","author":"Doyle","year":"2007","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD001146.pub5-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1542\/peds.95.4.584","article-title":"Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial","volume":"95","author":"Durand","year":"1995","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD001146.pub5-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0022-3476(99)70284-2","article-title":"Single-dose dexamethasone treatment of hypotension in preterm infants","volume":"134","author":"Gaissmaier","year":"1999","journal-title":"Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD001146.pub5-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1542\/peds.2004-0956","article-title":"Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease","volume":"115","author":"Gross","year":"2005","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD001146.pub5-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0022-3476(89)80754-1","article-title":"Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants: a controlled trial","volume":"115","author":"Harkavy","year":"1989","journal-title":"Journal of Pediatrics"},{"issue":"5 Spec No","key":"10.1002\/14651858.CD001146.pub5-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1136\/adc.68.5_Spec_No.566","article-title":"Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia","volume":"68","author":"Kari","year":"1993","journal-title":"Archives of Disease in Childhood"},{"issue":"3","key":"10.1002\/14651858.CD001146.pub5-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1203\/00006450-199409000-00020","article-title":"Dexamethasone treatment of infants at risk for chronic lung disease: surfactant components and inflammatory parameters in airway specimens","volume":"36","author":"Kari","year":"1994","journal-title":"Pediatric Research"},{"issue":"8","key":"10.1002\/14651858.CD001146.pub5-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1651-2227.2003.tb00621.x","article-title":"Controlled trial of dexamethasone in neonatal chronic lung disease: an 8-year follow-up of cardiopulmonary function and growth","volume":"92","author":"Mieskonen","year":"2003","journal-title":"Acta Paediatrica"},{"issue":"5","key":"10.1002\/14651858.CD001146.pub5-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1542\/peds.86.5.722","article-title":"Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation","volume":"86","author":"Kazzi","year":"1990","journal-title":"Pediatrics"},{"issue":"6 Pt 1","key":"10.1002\/14651858.CD001146.pub5-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1542\/peds.97.6.818","article-title":"Cardiac effects of dexamethasone in very low birth weight infants","volume":"97","author":"Bensky","year":"1996","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD001146.pub5-BIB0085|cit85","first-page":"310A","article-title":"Developmental outcome at 5 years following dexamethasone use for very low birth weight infants","volume":"47","author":"Goldstein","year":"2000","journal-title":"Pediatric Research"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD001146.pub5-BIB0086|cit86","first-page":"22-7 Erratum in","article-title":"Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants","volume":"104","author":"Kothadia","year":"1999","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD001146.pub5-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jpeds.2006.12.013","article-title":"Follow-up study of a randomized controlled trial of postnatal dexamethasone therapy in very low birth weight infants: effects on pulmonary outcomes at age 8 to 11 years","volume":"150","author":"Nixon","year":"2007","journal-title":"Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD001146.pub5-BIB0088|cit88","first-page":"319A","article-title":"Randomized trial of a 42-day tapering course of dexamethasone in very low birth weight infants: neurological, medical and functional outcome at 5 years of age","volume":"47","author":"O'Shea","year":"2000","journal-title":"Pediatric Research"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD001146.pub5-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1542\/peds.104.1.15","article-title":"Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age","volume":"104","author":"O'Shea","year":"1999","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD001146.pub5-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1542\/peds.2006-0973","article-title":"Follow-up of a randomized, placebo-controlled trial of postnatal dexamethasone: blood pressure and anthropometric measurements at school age","volume":"118","author":"Washburn","year":"2006","journal-title":"Pediatrics"},{"issue":"7","key":"10.1002\/14651858.CD001146.pub5-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1651-2227.1998.tb01749.x","article-title":"Efficacy of sequential early systemic and inhaled corticosteroid therapy in the prevention of chronic lung disease of prematurity","volume":"87","author":"Kovacs","year":"1998","journal-title":"Acta Paediatrica"},{"issue":"4","key":"10.1002\/14651858.CD001146.pub5-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00444135","article-title":"Dexamethasone in neonatal chronic lung disease: pulmonary effects and intracranial complications","volume":"148","author":"Noble-Jamieson","year":"1989","journal-title":"European Journal of Pediatrics"},{"issue":"10","key":"10.1002\/14651858.CD001146.pub5-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1651-2227.1992.tb12096.x","article-title":"Randomized controlled trial of dexamethasone treatment in very-low-birth-weight infants with ventilator-dependent chronic lung disease","volume":"81","author":"Ohlsson","year":"1992","journal-title":"Acta Paediatrica"},{"issue":"16","key":"10.1002\/14651858.CD001146.pub5-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1056\/NEJM199804163381604","article-title":"A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants","volume":"338","author":"Papile","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD001146.pub5-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1542\/peds.104.5.e63","article-title":"Dexamethasone therapy increases infection in very low birth weight infants","volume":"104","author":"Stoll","year":"1999","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD001146.pub5-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jpeds.2012.09.054","article-title":"Pilot randomized trial of hydrocortisone in ventilator-dependent extremely preterm infants: effects on regional brain volumes","volume":"162","author":"Parikh","year":"2013","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD001146.pub5-BIB0097|cit97","first-page":"283","article-title":"Dexamethasone for the prevention of chronic lung disease in preterm neonates: a prospective randomized study","volume":"24","author":"Romagnoli","year":"1997","journal-title":"Rivista Italiana di Pediatria [Italian Journal of Pediatrics]"},{"issue":"1","key":"10.1002\/14651858.CD001146.pub5-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"F55","DOI":"10.1136\/fn.87.1.F55","article-title":"A three year follow up of preterm infants after moderately early treatment with dexamethasone","volume":"87","author":"Romagnoli","year":"2002","journal-title":"Archives of Disease in Childhood. Fetal and Neonatal Edition"},{"issue":"5","key":"10.1002\/14651858.CD001146.pub5-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000028329","article-title":"Effect on growth of two different dexamethasone courses for preterm infants at risk of chronic lung disease. A randomized trial","volume":"59","author":"Romagnoli","year":"1999","journal-title":"Pharmacology"},{"issue":"6","key":"10.1002\/14651858.CD001146.pub5-BIB0100|cit100","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.anpedi.2013.08.004","article-title":"Hydrocortisone for the treatment of refractory hypotension:a randomised controlled trial","volume":"80","author":"Salas","year":"2014","journal-title":"Anales de Pediatria (Barcelona, Spain : 2003)"},{"issue":"1","key":"10.1002\/14651858.CD001146.pub5-BIB0101|cit101","first-page":"24","article-title":"Effect of five days of dexamethasone therapy on ventilator dependence and adrenocorticotropic hormone-stimulated cortisol concentrations","volume":"17","author":"Scott","year":"1997","journal-title":"Journal of Perinatology"},{"issue":"6","key":"10.1002\/14651858.CD001146.pub5-BIB0102|cit102","doi-asserted-by":"publisher","first-page":"F517","DOI":"10.1136\/archdischild-2014-306619","article-title":"Experience with oral betamethasone in extremely low birthweight infants with bronchopulmonary dysplasia","volume":"99","author":"Smolkin","year":"2014","journal-title":"Archives of Disease in Childhood. Fetal and Neonatal Edition"},{"issue":"5","key":"10.1002\/14651858.CD001146.pub5-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000014170","article-title":"Early (4-7 days of age) dexamethasone therapy for prevention of chronic lung disease in preterm infants","volume":"76","author":"Tsukahara","year":"1999","journal-title":"Biology of the Neonate"},{"key":"10.1002\/14651858.CD001146.pub5-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"201A","DOI":"10.1203\/00006450-199804001-01195","article-title":"Double blind randomized controlled trial of 6-day pulse of dexamethasone for very low birth weight infants (VLBW <1500 grams) who are ventilator dependent at 4 weeks of age","volume":"43","author":"Vincer","year":"1998","journal-title":"Pediatric Research"},{"issue":"1","key":"10.1002\/14651858.CD001146.pub5-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0378-3782(03)00082-3","article-title":"Adrenal suppression and extubation rate after moderately early low-dose dexamethasone therapy in very preterm infants","volume":"74","author":"Walther","year":"2003","journal-title":"Early Human Development"},{"issue":"5","key":"10.1002\/14651858.CD001146.pub5-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/tropej\/45.5.304","article-title":"Early dexamethasone treatment in preterm infants treated with surfactant: a double blind controlled trial","volume":"45","author":"Yaseen","year":"1999","journal-title":"Journal of Tropical Pediatrics"},{"issue":"8773","key":"10.1002\/14651858.CD001146.pub5-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0140-6736(91)91843-J","article-title":"Dexamethasone for neonatal chronic lung disease","volume":"338","author":"[No authors","year":"1991","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD001146.pub5-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/(SICI)1099-0496(199909)28:3<167::AID-PPUL2>3.0.CO;2-Y","article-title":"Meta-analysis of dexamethasone therapy started in the first 15 days of life for prevention of chronic lung disease in premature infants","volume":"28","author":"Arias-Camison","year":"1999","journal-title":"Pediatric Pulmonology"},{"issue":"16","key":"10.1002\/14651858.CD001146.pub5-BIB0109|cit109","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1056\/NEJM199910143411604","article-title":"Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very preterm infants","volume":"341","author":"Baud","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001146.pub5-BIB0110|cit110","volume-title":"Bayley Scales of Infant Development","author":"Bayley","year":"1993"},{"issue":"1","key":"10.1002\/14651858.CD001146.pub5-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"F26","DOI":"10.1136\/fn.79.1.F26","article-title":"Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease","volume":"79","author":"Bhuta","year":"1998","journal-title":"Archives of Disease in Childhood. Fetal and Neonatal Edition"},{"issue":"2","key":"10.1002\/14651858.CD001146.pub5-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1440-1754.2000.00481.x","article-title":"Postnatal corticosteroids in preterm infants: systematic review of effects on mortality and motor function","volume":"36","author":"Doyle","year":"2000","journal-title":"Journal of Paediatrics and Child Health"},{"issue":"2","key":"10.1002\/14651858.CD001146.pub5-BIB0113|cit113","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000279992","article-title":"Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review","volume":"98","author":"Doyle","year":"2010","journal-title":"Neonatology"},{"issue":"3","key":"10.1002\/14651858.CD001146.pub5-BIB0114|cit114","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000286210","article-title":"Dexamethasone treatment in the first week of life for preventing bronchopulmonary dysplasia in preterm infants: a systematic review","volume":"98","author":"Doyle","year":"2010","journal-title":"Neonatology"},{"issue":"4","key":"10.1002\/14651858.CD001146.pub5-BIB0115|cit115","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000286212","article-title":"Dexamethasone treatment after the first week of life for bronchopulmonary dysplasia in preterm infants: a systematic review","volume":"98","author":"Doyle","year":"2010","journal-title":"Neonatology"},{"issue":"5","key":"10.1002\/14651858.CD001146.pub5-BIB0116|cit116","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001145.pub3","article-title":"Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants","author":"Doyle","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD001146.pub5-BIB0117|cit117","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001145.pub4","article-title":"Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants","author":"Doyle","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD001146.pub5-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1542\/peds.100.1.e4","article-title":"Mortality, severe respiratory distress syndrome and chronic lung disease of the newborn are reduced more after prophylactic than after therapeutic administration of the surfactant Curosurf","volume":"100","author":"Egberts","year":"1997","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD001146.pub5-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1542\/peds.53.6.877","article-title":"Sequelae of early steroid administration to the newborn infant","volume":"53","author":"Fitzhardinge","year":"1974","journal-title":"Pediatrics"},{"issue":"5 Spec No","key":"10.1002\/14651858.CD001146.pub5-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/adc.69.5_Spec_No.505","article-title":"Growth retardation after dexamethasone administration: assessment by knemometry","volume":"69","author":"Gibson","year":"1993","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD001146.pub5-BIB0121|cit121","unstructured":"GRADE Working Group, McMaster University (developed by Evidence Prime) GRADEpro GDT 2015. Available from gradepro.org"},{"issue":"1","key":"10.1002\/14651858.CD001146.pub5-BIB0122|cit122","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1203\/00006450-199807000-00017","article-title":"The influence of betamethasone and dexamethasone on motor development in young rats","volume":"44","author":"Gramsbergen","year":"1998","journal-title":"Pediatric Research"},{"issue":"1","key":"10.1002\/14651858.CD001146.pub5-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1136\/fn.73.1.F1","article-title":"Inflammatory mediators and bronchopulmonary dysplasia","volume":"73","author":"Groneck","year":"1995","journal-title":"Archives of Disease in Childhood. Fetal and Neonatal Edition"},{"key":"10.1002\/14651858.CD001146.pub5-BIB0124|cit124","first-page":"1","article-title":"A review of postnatal corticosteroids for treatment and prevention of chronic lung disease in the preterm infant","volume":"2","author":"Halliday","year":"1997","journal-title":"Prenatal and Neonatal Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001146.pub5-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000047044","article-title":"Clinical trials of postnatal corticosteroids: inhaled and systemic","volume":"76","author":"Halliday","year":"1999","journal-title":"Biology of the Neonate"},{"key":"10.1002\/14651858.CD001146.pub5-BIB0126|cit126","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"8338","key":"10.1002\/14651858.CD001146.pub5-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0140-6736(83)92139-6","article-title":"Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia","volume":"1","author":"Mammel","year":"1983","journal-title":"Lancet"},{"issue":"3 Spec No","key":"10.1002\/14651858.CD001146.pub5-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/adc.68.3_Spec_No.330","article-title":"The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia","volume":"68","author":"Ng","year":"1993","journal-title":"Archives of Disease in Childhood"},{"issue":"8","key":"10.1002\/14651858.CD001146.pub5-BIB0129|cit129","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002311.pub4","article-title":"Late (\u2265 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants","author":"Onland","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001146.pub5-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"236A","DOI":"10.1203\/00006450-199604001-01422","article-title":"Dexamethasone therapy in infants at risk for chronic lung disease (CLD): a multicenter, randomized, double-masked trial","volume":"39","author":"Papile","year":"1996","journal-title":"Pediatric Research"},{"issue":"3","key":"10.1002\/14651858.CD001146.pub5-BIB0131|cit131","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000164150","article-title":"Trial of early neonatal hydrocortisone: two-year follow-up","volume":"95","author":"Peltoniemi","year":"2009","journal-title":"Neonatology"},{"issue":"2","key":"10.1002\/14651858.CD001146.pub5-BIB0132|cit132","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/apa.13074","article-title":"Randomised trial of early neonatal hydrocortisone demonstrates potential undesired effects on neurodevelopment at preschool age","volume":"105","author":"Peltoniemi","year":"2016","journal-title":"Acta Paediatrica"},{"key":"10.1002\/14651858.CD001146.pub5-BIB0133|cit133","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"6","key":"10.1002\/14651858.CD001146.pub5-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1542\/peds.109.6.e85","article-title":"Controlled trial of early dexamethasone treatment for the prevention of chronic lung disease in preterm infants: a 3-year follow-up","volume":"109","author":"Romagnoli","year":"2002","journal-title":"Pediatrics"},{"issue":"8","key":"10.1002\/14651858.CD001146.pub5-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/BF01957150","article-title":"Prediction of chronic neonatal lung disease on day 4 of life","volume":"155","author":"Ryan","year":"1996","journal-title":"European Journal of Pediatrics"},{"issue":"20","key":"10.1002\/14651858.CD001146.pub5-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1056\/NEJMoa054065","article-title":"Caffeine therapy for apnea of prematurity","volume":"354","author":"Schmidt","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001146.pub5-BIB0137|cit137","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A GRADE Working Group GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations Available from https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html. Updated October 2013"},{"issue":"4","key":"10.1002\/14651858.CD001146.pub5-BIB0138|cit138","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001969.pub2","article-title":"Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates","author":"Shah","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD001146.pub5-BIB0139|cit139","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002058.pub2","article-title":"Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates","author":"Shah","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD001146.pub5-BIB0140|cit140","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002057.pub3","article-title":"Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants","author":"Shah","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD001146.pub5-BIB0141|cit141","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001969.pub4","article-title":"Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates","author":"Shahh","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD001146.pub5-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"F177","DOI":"10.1136\/fn.83.3.F177","article-title":"Early postnatal dexamethasone treatment and increased incidence of cerebral palsy","volume":"83","author":"Shinwell","year":"2000","journal-title":"Archives of Disease in Childhood. Fetal and Neonatal Edition"},{"issue":"1","key":"10.1002\/14651858.CD001146.pub5-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1469-8749.1982.tb13594.x","article-title":"Using cerebral palsy data in the evaluation of neonatal intensive care: a warning","volume":"24","author":"Stanley","year":"1982","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"1","key":"10.1002\/14651858.CD001146.pub5-BIB0144|cit144","doi-asserted-by":"publisher","first-page":"34-9 e2","DOI":"10.1016\/j.jpeds.2013.07.027","article-title":"Death or neurodevelopmental impairment at 18 to 22 months corrected age in a randomized trial of early dexamethasone to prevent death or chronic lung disease in extremely low birth weight infants","volume":"164","author":"Stark","year":"2014","journal-title":"Journal of Pediatrics"},{"issue":"7222","key":"10.1002\/14651858.CD001146.pub5-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1136\/bmj.319.7222.1385","article-title":"Postnatal dexamethasone in preterm infants is potentially life saving, but follow up studies are urgently needed","volume":"319","author":"Tarnow-Mordi","year":"1999","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD001146.pub5-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000244241","article-title":"Influence of postnatally administered glucocorticoids on rat lung growth","volume":"68","author":"Tschanz","year":"1995","journal-title":"Biology of the Neonate"},{"issue":"1","key":"10.1002\/14651858.CD001146.pub5-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0022-3476(94)70265-9","article-title":"Effect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasia","volume":"124","author":"Goudoever","year":"1994","journal-title":"Journal of Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD001146.pub5-BIB0148|cit148","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1542\/peds.2006-3158","article-title":"Growth and developmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants","volume":"120","author":"Watterberg","year":"2007","journal-title":"Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD001146.pub5-BIB0149|cit149","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/ana.410020503","article-title":"The therapeutic use of glucocorticoid hormones in the perinatal period: potential neurologic hazards","volume":"2","author":"Weichsel","year":"1977","journal-title":"Annals of Neurology"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD001146.pub5-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0022-3476(05)80446-9","article-title":"Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia","volume":"120","author":"Werner","year":"1992","journal-title":"Journal of Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD001146.pub5-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1542\/peds.101.5.e7","article-title":"Early dexamethasone therapy in preterm infants: a follow up study","volume":"101","author":"Yeh","year":"1998","journal-title":"Pediatrics"},{"issue":"13","key":"10.1002\/14651858.CD001146.pub5-BIB0152|cit152","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1056\/NEJMoa032089","article-title":"Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity","volume":"350","author":"Yeh","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD001146.pub5-BIB0153|cit153","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001146.pub4","article-title":"Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants","author":"Doyle","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD001146.pub5-BIB0154|cit154","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001146","article-title":"Early postnatal (< 96 hours) corticosteroids for preventing chronic lung disease in preterm infants","author":"Halliday","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD001146.pub5-BIB0155|cit155","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001146","article-title":"Early postnatal (< 96 hours) corticosteroids for preventing chronic lung disease in preterm infants","author":"Halliday","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD001146.pub5-BIB0156|cit156","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001146","article-title":"Early (< 96 hours) postnatal corticosteroids for preventing chronic lung disease in preterm infants","author":"Halliday","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD001146.pub5-BIB0157|cit157","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001146.pub3","article-title":"Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants","author":"Halliday","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd001146.pub6","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001146.pub5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T03:56:28Z","timestamp":1659671788000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001146.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Neonatal Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,24]]},"references-count":157,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001146.pub5","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD001146.pub6","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,24]]}}}